Glaxo adds birth defect caution to Paxil label
GlaxoSmithKline Plc is alerting physicians about a study suggesting the company's antidepressant Paxil may be linked more often to birth defects than similar drugs, U.S. regulators said on Tuesday. The British drug…
2 min read